iShares Biotechnology ETF (IBB)
| 138.43 Delayed Data As of Dec 02 |  +1.27 / +0.93%Today’s Change | 104.29 Today|||52-Week Range 155.17 | -9.30% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Latest IBB News
| Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? Dec 01 / Zacks.com - Paid Partner Content | Should You Invest in the VanEck Biotech ETF (BBH)? Nov 22 / Zacks.com - Paid Partner Content |
| Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? Nov 23 / Zacks.com - Paid Partner Content |
Performance
| 1 month | +8.51% | 3 years | +5.62% | |
| 3 months | +14.30% | 5 years | +5.81% | |
| 1 year | -8.24% | Since inception | +6.92% |
Data through 12/03/2022
Quote Details
| Previous close | $137.16 |
| Open day’s range | 135.53 – 138.74 |
| Net asset value (NAV) | 138.41 (12/02/2022) |
| Daily volume | 383,233 |
| Average volume (3 months) | 1,937,304 |
Data as of 4:00pm ET, 12/02/2022
Peer Comparisonvs. Health ETFs
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +5.81% | +5.91% |
| Expense Gross exp ratio | 0.44% | 1.00% |
| Risk 5 year sharpe ratio | 0.25 | 0.45 |
| Net assets | $8.0B | $2.0B |
| Average market cap | $21.3B | $49.7B |
| Average P/E | 14.5 | 23.2 |
| Dividend / Share | -- | 0.27% |
Competitors
| FHLC Fidelity MSCI Health Care Index ETF |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| XLV Health Care Select Sector SPDR® Fund |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| GILD Gilead Sciences | 9.35% |
| AMGN Amgen | 8.62% |
| VRTX Vertex Pharmaceuticals Inc | 7.59% |
| REGN Regeneron Pharmaceuticals | 7.31% |
| MRNA Moderna Inc | 4.83% |
| BIIB Biogen | 3.90% |
| IQV IQVIA Holdings Inc | 3.69% |
| ILMN Illumina Inc | 3.41% |
| MTD Mettler-Toledo International Inc | 2.67% |
| BNTX BioNTech SE | 2.47% |
